83 related articles for article (PubMed ID: 372624)
21. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
Niessner H
Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis of Von Willebrand's syndrome (author's transl)].
Hariga-Muller C; Capel P; De Maertelaere-Laurent E; Masramon AM; Fondu P
Rev Med Brux; 1981 Mar; 2(3):245-50. PubMed ID: 6785854
[No Abstract] [Full Text] [Related]
23. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
24. [Platelet function: With special reference to collagen-platelet reaction (author's transl)].
Yamanaka M; Nagai Y; Matsuda M; Isobe J
Rinsho Ketsueki; 1975 Apr; 16(4):387-95. PubMed ID: 1079884
[No Abstract] [Full Text] [Related]
25. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
[TBL] [Abstract][Full Text] [Related]
26. [IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation)].
Boda Z; Hársfalvi J; Rák K
Orv Hetil; 1985 Aug; 126(32):1957-60. PubMed ID: 2993980
[No Abstract] [Full Text] [Related]
27. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
28. Proceedings: Two cases of von Willebrand's disease with specific inhibitors of ristocetin induced aggregation of normal platelets.
Blombäck M; Egberg N
Thromb Diath Haemorrh; 1975 Nov; 34(2):583. PubMed ID: 1081749
[No Abstract] [Full Text] [Related]
29. [Von Willebrand's disease. Studies on platelet function, ristocetin induced platelet aggregation and factor VIII related antigen (author's transl)].
Mimaya J; Nagao T; Iizuka A; Yamashita H
Rinsho Ketsueki; 1975 Aug; 16(8):775-84. PubMed ID: 1081150
[No Abstract] [Full Text] [Related]
30. Plasma components which interfere with ristocetin-induced platelet aggregation.
Baugh RF; Brown JE; Hougie C
Thromb Diath Haemorrh; 1975 Jun; 33(3):540-6. PubMed ID: 1080300
[TBL] [Abstract][Full Text] [Related]
31. [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].
Yoshioka A; Takahashi Y
Rinsho Byori; 1983 Nov; 31(11):1176-85. PubMed ID: 6423868
[No Abstract] [Full Text] [Related]
32. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
33. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
Coller BS
J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
[TBL] [Abstract][Full Text] [Related]
34. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.
Favaloro EJ; Patterson D; Denholm A; Mead S; Gilbert A; Collins A; Estell J; George PM; Smith MP
Br J Haematol; 2007 Nov; 139(4):623-6. PubMed ID: 17916098
[No Abstract] [Full Text] [Related]
35. Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH.
Coller BS; Gralnick HR
Thromb Diath Haemorrh; 1975 Nov; 34(2):581-2. PubMed ID: 809
[No Abstract] [Full Text] [Related]
36. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
Coller BS; Hirschman RJ; Gralnick HR
Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
[No Abstract] [Full Text] [Related]
37. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
38. Ristocetin and von Willebrand factor analysis.
Light J; Williams CE; Entwistle MB
Med Lab Sci; 1987 Jul; 44(3):272-9. PubMed ID: 3501515
[No Abstract] [Full Text] [Related]
39. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
[TBL] [Abstract][Full Text] [Related]
40. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
